Our purpose is to fund research. We met Ria, and her project in Dr. Kenneth van Golen’s lab at the University of Delaware has some interesting questions that need to be answered. We have made a commitment to her and Dr. van Golen to support this research. IBC...
Alternative Drug Names: PLX-3397 is also called Pexidartinib. MK-3475 is now Pembrolizumab (Keytruda brand in the US). Purpose of Trial: The purpose of this phase 1/2 study is to establish the safety of the combination of these 2 agents in any solid tumor, and in the...
Alternative Drug Names: Nab-Paclitaxel (Abraxane brand in the US), Trastuzumab (Herceptin is the brand in the US and abroad), Pertuzumab (Perjeta brand in the US and abroad) Purpose of Trial: The purpose of this phase 2 study is to evaluate the effectiveness of the 3...
Alternative Drug Names: Ruxolitinib (Jakafi brand in the US) was previously also known as INCB018242. Purpose of Trial: The purpose of this phase 1/2 study is 2-fold. In the first part of the study in metastatic breast cancer patients, the goal is to determine a safe...
Alternative Drug Names: Paclitaxel (Taxol brand in the US and abroad), Trastuzumab (Herceptin is the brand in the US and abroad), Pertuzumab (Perjeta brand in the US and abroad) Purpose of Trial: The purpose of this phase 2 study is to evaluate the effectiveness of...
Alternative Drug Names: Nintedanib was called BIBF 1120 (Ofev brand in the US) Purpose of Trial: The purpose of this phase 2 study is to evaluate the safety and efficacy of Nintedanib in the setting of metastatic IBC. Nintedanib is FDA approved outside of oncology,...